Profile
Dr. Richard E.
Gilbert is a Member-Scientific Advisory Board at Fibrotech Therapeutics Pty Ltd. and a Professor at University of Toronto.
Dr. Gilbert was previously employed as a Principal by GlaxoSmithKline, Inc., a Principal by Eli Lilly & Co., and a Principal by Merck & Co., Inc.
Richard Ernest Gilbert active positions
| Companies | Position | Start |
|---|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-05-31 |
Former positions of Richard Ernest Gilbert
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Health Technology |
- Stock Market
- Insiders
- Richard Ernest Gilbert
















